Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Division of Radiation Oncology, Department of Hemato-Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Radiother Oncol. 2018 Jan;126(1):81-88. doi: 10.1016/j.radonc.2017.10.015. Epub 2017 Oct 27.
To evaluate the benefit of oral nutritional supplements (ONS) in addition to nutritional counseling in head and neck cancer (HNC) patients undergoing radiotherapy (RT).
In a single-center, randomized, pragmatic, parallel-group controlled trial (ClinicalTrials.gov: NCT02055833; February 2014-August 2016), 159 newly diagnosed HNC patients suitable for to RT regardless of previous surgery and induction chemotherapy were randomly assigned to nutritional counseling in combination with ONS (N = 78) or without ONS (N = 81) from the start of RT and continuing for up to 3 months after its end. Primary endpoint was the change in body weight at the end of RT. Secondary endpoints included changes in protein-calorie intake, muscle strength, phase angle and quality of life and anti-cancer treatment tolerance.
In patients with the primary endpoint assessed (modified intention-to-treat population), counseling plus ONS (N = 67) resulted in smaller loss of body weight than nutritional counseling alone (N = 69; mean difference, 1.6 kg [95%CI, 0.5-2.7]; P = 0.006). Imputation of missing outcomes provided consistent findings. In the ONS-supplemented group, higher protein-calorie intake and improvement in quality of life over time were also observed (P < 0.001 for all). The use of ONS reduced the need for changes in scheduled anti-cancer treatments (i.e. for RT and/or systemic treatment dose reduction or complete suspension, HR=0.40 [95%CI, 0.18-0.91], P = 0.029).
In HNC patients undergoing RT or RT plus systemic treatment, and receiving nutritional counseling, the use of ONS resulted in better weight maintenance, increased protein-calorie intake, improved quality of life and was associated with better anti-cancer treatment tolerance.
评估在头颈部癌症(HNC)患者接受放疗(RT)时,除营养咨询外,口服营养补充(ONS)的益处。
在一项单中心、随机、实用、平行组对照试验(ClinicalTrials.gov:NCT02055833;2014 年 2 月至 2016 年 8 月)中,159 例新诊断的 HNC 患者适合接受 RT,无论是否接受过手术和诱导化疗,均从 RT 开始时随机分配至接受营养咨询联合 ONS(ONS 组,n=78)或不接受 ONS(对照组,n=81),并持续至 RT 结束后 3 个月。主要终点是 RT 结束时体重的变化。次要终点包括蛋白质-热量摄入、肌肉力量、相位角和生活质量以及抗癌治疗耐受性的变化。
在主要终点评估的患者中(意向治疗人群的改良分析),ONS 联合营养咨询(n=67)导致体重较单纯营养咨询(n=69)的损失更小(平均差异,1.6kg[95%CI,0.5-2.7];P=0.006)。对缺失结果的推断也提供了一致的发现。在接受 ONS 补充的患者中,还观察到蛋白质-热量摄入增加和生活质量随时间改善(所有 P<0.001)。ONS 的使用减少了改变计划中的抗癌治疗的需要(即 RT 和/或全身治疗剂量减少或完全暂停,HR=0.40[95%CI,0.18-0.91],P=0.029)。
在接受 RT 或 RT 联合全身治疗的 HNC 患者中,在接受营养咨询的同时使用 ONS 可更好地维持体重,增加蛋白质-热量摄入,改善生活质量,并与更好的抗癌治疗耐受性相关。